NCT04842643 - An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

April 25, 2024

Study Completion Date

April 25, 2024

Conditions

Primary Immunodeficiency Disease

Interventions

BIOLOGICAL

IGSC 20% infusion

IGSC 20% infusion,

Trial Locations (8)

Nagoya University Hospital, Nagoya

Kurume University Hospital, Kurume

Kanazawa University Hospital, Kanazawa

National defense medical college Hospital, Tokorozawa

Kyushu University Hospital, Fukuoka

Gifu University Hospital, Gifu

Hiroshima University Hospital, Hiroshima

Tokyo Medical Dental University Hospital, Tokyo